Roche Holding AG
SIX:ROG
Roche Holding AG
Depreciation & Amortization
Roche Holding AG
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Depreciation & Amortization
-CHf336m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-19%
|
|
Novartis AG
SIX:NOVN
|
Depreciation & Amortization
-$411m
|
CAGR 3-Years
-86%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Depreciation & Amortization?
Depreciation & Amortization
-336m
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Depreciation & Amortization amounts to -336m CHF.
What is Roche Holding AG's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-19%
Over the last year, the Depreciation & Amortization growth was 11%. The average annual Depreciation & Amortization growth rates for Roche Holding AG have been 9% over the past three years , -13% over the past five years , and -19% over the past ten years .